Affiliation:
1. Affiliated Zhejiang Hospital
2. Tongxiang First People's Hospital
Abstract
AbstractCisplatin (DDP) chemotherapy is effective to treat tumors but potentially limited to drug resistance. The research studied miR-6838-5p in controlling LC cells’ DDP resistance. First, clinical samples of DDP-resistant LC and DDP-sensitive LC were obtained and clinicopathological information was analyzed. Then, a DDP-resistant cell model (A549/DDP) was established and transfected with the plasmid vector that interfered with the expression of miR-6838-5p or SYPL1. Cell viability and half-maximal inhibitory concentration (IC50), apoptosis, migration and invasion were detected by CCK-8, flow cytometry, and Transwell, respectively. miR-6838-5p, SYPL1, MMP-2 and MMP-9 expression was determined by RT-qPCR or immunoblot analysis. Finally, the targeting relationship between miR-6838-5p and SYPL1 was verified by bioinformatics website and luciferase reporter assay. Experiment result showed that reduced miR-6838-5p and upregulated SYPL1 were presented in DDP-resistant LC. Elevating miR-6838-5p or suppressing SYPL1 repressed proliferative, migratory, and invasive activities and DDP resistance, but promoted apoptosis in A549/DDP cells. MiR-6838-5p targeted SYPL1. Moreover, SYPL1 overexpression turned around elevated miR-6838-5p-mediated effect on A549/DDP metastasis and DDP resistance. In conclusion, miR-6838-5p targets SYPL1 to restrain metastasis and DDP resistance of LC cells.
Publisher
Research Square Platform LLC
Reference51 articles.
1. Yu, S., et al., Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018. 97: p. 213–224.
2. Cao, L., et al., GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017. 93: p. 570–579.
3. Inhibition of JAK2/STAT3 signaling pathway protects mice from the DDP-induced acute kidney injury in lung cancer;Zhang L;Inflammation research: official journal of the European Histamine Research Society … et al.],2019
4. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J;Shi L;BMC cancer,2017
5. Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism;Huang Y;Medical science monitor: international medical journal of experimental and clinical research,2020